• Design of a Multivalent mRNA Vaccine to Protect Against Multiple Variants (No. T4-2136)

    The constant emergence of new variants threatens the success of the mRNA vaccines developed against SARS-CoV-2. Therefore, there is an urgent need to develop a vaccine that will provide immunity against multiple variants – both existing and potential. Prof. ... Read more
    Prof Yitzhak Pilpel

    Yitzhak Pilpel

    Faculty of Biochemistry

  • Novel Combination Therapy For Improved Management of Depression (No. T4-2129)

    Psychiatric disorders, especially major depressive disorder (MDD), are leading causes of disability and premature death across the globe, with patients showing a heightened risk of self-harm and suicidal ideation. Prof. ... Read more
    Full Professor Alon Chen

    Alon Chen

    Faculty of Biology

  • Modulating Weight Gain and Loss by Understanding the Mechanism of Smoking Related Weight Changes (No. T4-2078)

    Of the approximately 30 million adult smokers in the U.S, more than half report attempting to quit smoking every year. However, smoking cessation-associated weight gain (SCWG) constitutes a major obstacle to smoking withdrawal. ... Read more
    Associate Professor Eran Elinav

    Eran Elinav

    Faculty of Biology

  • Treatment for Ewing Sarcoma Using ETS Proteins (No. T4-2068)

    Ewing sarcoma (ES) is a common bone malignancy in children and young adolescents which is usually treated by systemic chemotherapy. In about 25% of the cases, cancer has already spread to other parts of the body at the time of diagnosis. ... Read more
    Extension Service Yosef Yarden

    Yosef Yarden

    Faculty of Biology

  • Inhibitory Proteins for 20S Proteasome Regulation as Cancer Treatment (No. T4-2065)

    Proteasomal protein degradation is crucial in maintaining cellular integrity and in regulating key cellular processes including cell cycle, proliferation and cell death. ... Read more
    Associate Professor Michal Sharon

    Michal Sharon

    Faculty of Biochemistry

  • Increasing Immunotherapy Efficacy of Anti PD-L1 (No. T4-2059)

    Immunotherapy has revolutionized cancer treatment by activating the immune system to attack tumor cells. However, notable limitations remain, including differential responses between individuals and cancer types. Dr. ... Read more
    Prof Rony Dahan

    Rony Dahan

    Faculty of Biology

  • Peptides for Treating Alzheimer's Disease (No. T4-2057)

    Alzheimer's Disease (AD) is an age-associated neurodegenerative disorder characterized clinically by a decline in cognitive function. It is the most common type of dementia, with 5.8 million Americans living with AS in 2020. ... Read more
    Full Professor Ruth Arnon

    Ruth Arnon

    Faculty of Biology

  • Safer CAR-T Cell Platform (No. T4-2033)

    Chimeric Antigen Receptor (CAR)-T Cell Therapy is a personalized treatment for cancer in which the patient's T cells are genetically engineered to express a synthetic receptor that binds a tumor antigen. ... Read more
    Associate Professor Sarel FLEISHMAN

    Sarel-Jacob Fleishman

    Faculty of Biochemistry

  • Biologic Drug for Prevention and Treatment of COVID-19 (No. T4-2024)

    Combat against COVID-19 is still ongoing worldwide. ... Read more
    Full Professor Gideon Schreiber

    Gideon Schreiber

    Faculty of Biochemistry

    Full Professor Yinon Rudich

    Yinon Rudich

    Faculty of Chemistry

  • Small Molecules for Treatment of Huntington's Disease and Related Disorders (No. T4-1947)

    Trinucleotide repeats expansion disorders (TREDs) are a set of diseases in which repetitions of short DNA segments (three nucleotides) occur and accumulate in the genome. ... Read more
    Full Professor Rivka Dikstein

    Rivka Dikstein

    Faculty of Biochemistry



Subscribe to Pharmaceuticals